Capstone Investment Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$384K Buy
8,950
+1,419
+19% +$61K ﹤0.01% 1267
2025
Q4
$330K Sell
7,531
-4,793
-39% -$198K ﹤0.01% 1304
2025
Q3
$509K Sell
12,324
-5,882
-32% -$236K ﹤0.01% 1362
2025
Q2
$802K Buy
+18,206
New +$728K ﹤0.01% 934
2024
Q4
Sell
-24,070
Closed -$625K 1900
2024
Q3
$625K Buy
+24,070
New +$598K ﹤0.01% 1130
2023
Q4
Sell
-23,282
Closed -$509K 2194
2023
Q3
$509K Buy
+23,282
New +$487K ﹤0.01% 1319
2017
Q1
Sell
-29,500
Closed -$439K 953
2016
Q4
$439K Buy
+29,500
New +$426K 0.01% 612
2014
Q2
Sell
-148,300
Closed -$524K 416
2014
Q1
$524K Buy
+148,300
New +$1.01M 0.01% 328

Other funds holding EXEL

Capstone Investment Advisors's EXEL Position: Q1 2026 in Review

Capstone Investment Advisors increased its Exelixis (EXEL) stake by 19% in Q1 2026, buying an estimated $61K and bringing the position to 8,950 shares worth $384K. The position accounts for ﹤0.01% of the portfolio, ranked #1267.

Capstone Investment Advisors first reported a position in EXEL in Q1 2014 and has held it in 8 quarters since. The position peaked at $802K in Q2 2025. 697 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Capstone Investment Advisors held 8,950 shares of Exelixis worth $384K as of Q1 2026.
  • Capstone Investment Advisors bought 1,419 Exelixis shares in Q1 2026, an estimated $61K.
  • Exelixis made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #1267 holding.
  • Capstone Investment Advisors first reported a position in Exelixis in Q1 2014 and has held it in 8 quarters since.
  • Capstone Investment Advisors's Exelixis position peaked at $802K in Q2 2025.
  • 697 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.